IVIg for relapsing-remitting multiple sclerosis: promises and uncertainties. Bayry J, Hartung H-P, Kaveri SV Trends Pharmacol Sci. 2015 May 20. PMID: 26003802. Abstract CommentRecommendBookmarkWatch